Biocon arm inks pact with US firm

The partnership establishes a cost-efficient global footprint for clinical pharmacology services, providing an opportunity to engage pharmaceutical clients strategically, Biocon said.

World over, pharmaceutical clients are increasingly seeking strategies to expedite their early clinical development and streamlining processes and the partnership is designed to deliver this in a cost-effective manner, Clinigene said.

DH Newsletter Privacy Policy Get the top news in your inbox
Comments (+)